[{"address1": "1800 Sierra Point Parkway", "address2": "Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 484 0899", "website": "https://dayonebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.", "fullTimeEmployees": 184, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Bender M.B.A., Ph.D.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1195600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles N. York II, M.B.A.", "age": 47, "title": "COO & CFO", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 854200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Dubow J.D.", "age": 57, "title": "General Counsel, Chief Compliance Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 692700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Stubenrauch Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Heather Adkins Huet Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joey  Perrone", "title": "Senior Vice President of Finance & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaa  Roberson", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davy  Chiodin Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Merendino M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elly  Barry M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.85, "open": 8.77, "dayLow": 8.56, "dayHigh": 9.05, "regularMarketPreviousClose": 8.85, "regularMarketOpen": 8.77, "regularMarketDayLow": 8.56, "regularMarketDayHigh": 9.05, "payoutRatio": 0.0, "beta": -1.255, "forwardPE": -7.857143, "volume": 3542455, "regularMarketVolume": 3542455, "averageVolume": 1719176, "averageVolume10days": 4208760, "averageDailyVolume10Day": 4208760, "bid": 8.75, "ask": 8.82, "bidSize": 10, "askSize": 10, "marketCap": 910229760, "fiftyTwoWeekLow": 5.635, "fiftyTwoWeekHigh": 14.46, "allTimeHigh": 28.699, "allTimeLow": 5.44, "priceToSalesTrailing12Months": 6.8094273, "fiftyDayAverage": 7.5786, "twoHundredDayAverage": 7.71445, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 454857408, "profitMargins": -1.1353, "floatShares": 78966702, "sharesOutstanding": 102675502, "sharesShort": 9068852, "sharesShortPriorMonth": 10724894, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0883, "heldPercentInsiders": 0.16896, "heldPercentInstitutions": 0.83882004, "shortRatio": 5.95, "shortPercentOfFloat": 0.1306, "impliedSharesOutstanding": 103435196, "bookValue": 4.391, "priceToBook": 2.0040994, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -151758000, "trailingEps": -1.52, "forwardEps": -1.12, "enterpriseToRevenue": 3.403, "enterpriseToEbitda": -2.801, "52WeekChange": -0.31975406, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 8.8, "targetHighPrice": 34.0, "targetLowPrice": 16.0, "targetMeanPrice": 23.77778, "targetMedianPrice": 25.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 451580000, "totalCashPerShare": 4.398, "ebitda": -162410000, "totalDebt": 2893000, "quickRatio": 8.293, "currentRatio": 8.677, "totalRevenue": 133672000, "debtToEquity": 0.642, "revenuePerShare": 1.299, "returnOnAssets": -0.18575001, "returnOnEquity": -0.30161, "grossProfits": 119561000, "freeCashflow": -59989000, "operatingCashflow": -119616000, "revenueGrowth": -0.576, "grossMargins": 0.89444, "ebitdaMargins": -1.21499, "operatingMargins": -0.6094, "financialCurrency": "USD", "symbol": "DAWN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622122200000, "postMarketChangePercent": 0.6818121, "postMarketPrice": 8.86, "postMarketChange": 0.059999466, "regularMarketChange": -0.0500002, "regularMarketDayRange": "8.56 - 9.05", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1719176, "fiftyTwoWeekLowChange": 3.165, "fiftyTwoWeekLowChangePercent": 0.5616681, "fiftyTwoWeekRange": "5.635 - 14.46", "fiftyTwoWeekHighChange": -5.66, "fiftyTwoWeekHighChangePercent": -0.3914246, "fiftyTwoWeekChangePercent": -31.975407, "earningsTimestamp": 1762290000, "earningsTimestampStart": 1762290000, "earningsTimestampEnd": 1762290000, "earningsCallTimestampStart": 1762291800, "earningsCallTimestampEnd": 1762291800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.52, "epsForward": -1.12, "epsCurrentYear": -0.96025, "priceEpsCurrentYear": -9.16428, "fiftyDayAverageChange": 1.2214003, "fiftyDayAverageChangePercent": 0.16116437, "twoHundredDayAverageChange": 1.0855503, "longName": "Day One Biopharmaceuticals, Inc.", "twoHundredDayAverageChangePercent": 0.1407165, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-27", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -0.564974, "regularMarketPrice": 8.8, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1763162441, "regularMarketTime": 1763154002, "exchange": "NMS", "messageBoardId": "finmb_704589075", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Day One Biopharmaceuticals, Inc", "displayName": "Day One Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]